The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 30, 2016

Filed:

Jan. 07, 2012
Applicants:

Dengming Xiao, Beijing, CN;

Liang Cheng, Beijing, CN;

Xijie Liu, Beijing, CN;

Yuandong HU, Beijing, CN;

Xinhe Xu, Beijing, CN;

Zhihua Liu, Beijing, CN;

Lipeng Zhang, Beijing, CN;

Wei Wu, Beijing, CN;

Shulong Wang, Beijing, CN;

Yu Shen, Beijing, CN;

Gen LI, Beijing, CN;

Yin Wang, Beijing, CN;

Sheng Zhao, Beijing, CN;

Chonglong LI, Beijing, CN;

Jia Tang, Beijing, CN;

Honghao Yu, Beijing, CN;

Inventors:

Dengming Xiao, Beijing, CN;

Liang Cheng, Beijing, CN;

Xijie Liu, Beijing, CN;

Yuandong Hu, Beijing, CN;

Xinhe Xu, Beijing, CN;

Zhihua Liu, Beijing, CN;

Lipeng Zhang, Beijing, CN;

Wei Wu, Beijing, CN;

Shulong Wang, Beijing, CN;

Yu Shen, Beijing, CN;

Gen Li, Beijing, CN;

Yin Wang, Beijing, CN;

Sheng Zhao, Beijing, CN;

Chonglong Li, Beijing, CN;

Jia Tang, Beijing, CN;

Honghao Yu, Beijing, CN;

Assignee:
Attorney:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07D 413/12 (2006.01); A61K 31/519 (2006.01); A61K 31/5377 (2006.01); A61K 31/541 (2006.01); A61K 31/4523 (2006.01); A61P 35/00 (2006.01); C07D 401/12 (2006.01); C07D 493/12 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/4523 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 31/541 (2013.01); C07D 401/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 493/12 (2013.01);
Abstract

The invention relates to a novel class of 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as a FAK and/or Pyk2 inhibitor, to a process for their preparation, and to a composition thereof, as well as to use of the compounds for the inhibiting FAK and/or Pyk2 and method for the treatment of a FAK and/or Pyk2 mediated disorder or disease.


Find Patent Forward Citations

Loading…